HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission goals

This article was originally published in The Rose Sheet

Executive Summary

Developing a proposal to simplify cosmetics legislation "for business competitiveness and better consumer safety" is one priority for the EU's Enterprise Directorate General in 2005, the agency says in a goals and activities document released Sept. 3. "This is an area where a large body of legislation has accumulated as a result of successive acts dealing with specific issues," Enterprise DG notes. The agency plans to conduct an "analysis of the competitive position of the sector...[which] will help to define the appropriate framework" for cosmetics legislation. Other priorities include implementation of the REACH chemicals program...

Developing a proposal to simplify cosmetics legislation "for business competitiveness and better consumer safety" is one priority for the EU's Enterprise Directorate General in 2005, the agency says in a goals and activities document released Sept. 3. "This is an area where a large body of legislation has accumulated as a result of successive acts dealing with specific issues," Enterprise DG notes. The agency plans to conduct an "analysis of the competitive position of the sector...[which] will help to define the appropriate framework" for cosmetics legislation. Other priorities include implementation of the REACH chemicals program....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012439

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel